Detalhe da pesquisa
1.
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 164(3): 607-616, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728779
2.
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses.
J Neurooncol
; 165(2): 387, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921974
3.
Identification of a B cell-dependent subpopulation of multiple sclerosis by measurements of brain-reactive B cells in the blood.
Clin Immunol
; 152(1-2): 20-4, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24607792
4.
Distress in Neuro-Oncology Patients and Its Implications for Communication.
J Adv Pract Oncol
; 14(4): 292-299, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37313277
5.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Sci Rep
; 5: 14265, 2015 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26387426